Key facts
- This page summarizes James Warner's Form 4 filing for Criteo S.A. (CRTO).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 15 Dec 2022, 15:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).
Footnote F3
For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
Footnote F4
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023.
Footnote F6
Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023.